What are the treatment options for interstitial cystitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

A multimodal approach combining behavioral modifications, oral medications, and intravesical treatments should be implemented for managing inflammation and pain in interstitial cystitis/bladder pain syndrome (IC/BPS), with treatment selection based on symptom severity and patient characteristics. 1

First-Line Treatments: Behavioral and Self-Care Approaches

  • Self-care practices and behavioral modifications should be discussed with all patients as initial management strategies 1
  • Dietary modifications including avoidance of known bladder irritants (coffee, citrus, spicy foods) can reduce symptoms 1
  • Implementation of an elimination diet helps identify personal trigger foods 1
  • Stress management techniques such as meditation and imagery can help manage symptoms 1
  • Pelvic floor muscle relaxation (not strengthening exercises) can reduce symptoms 1
  • Bladder training with urge suppression helps manage frequency 1
  • Over-the-counter products like quercetin and calcium glycerophosphates may provide relief 2, 1

Second-Line Treatments

Oral Medications

  • Amitriptyline (10-100 mg daily) is recommended with Grade B evidence strength 1
  • Pentosan polysulfate (100 mg three times daily) is the only FDA-approved oral medication for IC/BPS 1
  • Cimetidine and hydroxyzine are additional second-line oral medication options 2

Intravesical Treatments

  • Dimethyl sulfoxide (DMSO) - administered as 50 mL instillation directly into the bladder for 15 minutes, repeated every two weeks until maximum relief is obtained 2, 3
  • Heparin - helps repair the damaged glycosaminoglycan (GAG) layer 1
  • Lidocaine - provides temporary relief of bladder pain 1

Treatment for Hunner Lesions

  • Cystoscopy should be performed in patients for whom Hunner lesions are suspected 2
  • If Hunner's lesions are present, fulguration (with laser or electrocautery) and/or injection of triamcinolone should be performed 2, 4
  • Hunner lesions can be easier to identify after distention when cracking and mucosal bleeding become evident 2

Advanced Treatment Options (Third to Fifth Line)

  • Sacral neuromodulation may be considered if other treatments have not provided adequate symptom control 2, 5
  • Cyclosporine A may be administered as an oral medication for refractory cases 2
  • Intradetrusor botulinum toxin A injections may be beneficial, but patients must be willing to accept the possibility of needing intermittent self-catheterization 2

Pain Management

  • Multimodal pain management approaches should be initiated and maintained throughout treatment 2, 1
  • Pain management alone does not constitute sufficient treatment; underlying bladder symptoms must also be addressed 2
  • If pain management is inadequate, consider referral to pain specialists 2

Important Considerations and Pitfalls

  • Document baseline symptoms using validated tools such as the genitourinary pain index (GUPI) or interstitial cystitis symptom index (ICSI) to measure treatment effects 2
  • Avoid strengthening exercises for pelvic floor muscles, as these may worsen symptoms 1
  • Patients using pentosan polysulfate require regular ophthalmologic examinations due to risk of macular damage 1
  • Treatments that should NOT be offered include long-term oral antibiotic administration 4
  • DMSO administration may cause a garlic-like taste and odor on breath and skin for up to 72 hours 3
  • IC/BPS is a chronic condition; patients should be educated about the long-term nature of management 1, 4
  • Treatment efficacy for any individual is unpredictable; multiple therapeutic options may need to be tried before adequate symptom control is achieved 1, 6

References

Guideline

Treatment Options for Inflammation and Pain in Interstitial Cystitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Bladder Lesions in Women with IC and Painful Bladder Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.